 | FRI, APR 24, 2020 | | | | Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
Last week, hope emerged on Wall Street as some data on one of Gilead's remdesivir trials for Covid-19 leaked, indicating positive preliminary results. What a difference a week makes. There's now confusion as preliminary data from a different trial, this one in China, leaked and painted a very different picture. Meg Tirrell has the latest on where we stand now. U.S. health officials say they are preparing to battle two bad viruses circulating at the same time next fall: the coronavirus and the flu. Covid-19, which has sickened more than 2.7 million people worldwide and killed at least 191,231 as of Friday, has shown signs of slowing in the United States. But health officials warn it will continue to be a threat until there's a proven drug treatment and a vaccine, which is still 12 to 18 months away. Our team coverage on the outbreak below.
Programming update: Pfizer CEO Albert Bourla, Bristol-Myers Squibb CEO Giovanni Caforio and Epic Systems CEO Judy Faulkner are some of the latest speakers joining the Healthy Returns virtual summit on May 12. Learn more and request a complimentary ticket.
| | Another controversial cut of remdesivir data adds to confusing picture | The World Health Organization accidentally posted results from a prematurely halted clinical trial of Gilead's remdesivir from China Thursday, adding more fuel to an already raging fire about whether the drug actually works against Covid-19. The China trial was stopped because of troubles enrolling enough patients, as the outbreak there was on the decline – something the WHO's joint mission to China signaled back in February. But the conclusion posted on the WHO's website (before it was taken down) was that the study failed to improve outcomes. Gilead disputed that, noting the drug may show promise when given earlier in the course of the disease ... but we won't truly know until we see real, controlled clinical trial data — and that won't come until the end of May, when the NIH reports out its double-blind, placebo-controlled study.
-Meg Tirrell | | | | These high-risk Americans expect to shelter in place for a year or longer to avoid Covid-19 | As states begin to allow nonessential businesses to open their doors, many Americans will begin to cautiously emerge. But many of those considered high risk for severe complications of Covid-19 will not be among them. CNBC spoke to half-a-dozen people with conditions ranging from diabetes to Duchenne muscular dystrophy who are planning to shelter in place for a year or even longer.
-Chrissy Farr | | | | New York nurses' union sues state and two hospitals over 'war zone' conditions | The New York State Nurses Association filed suit earlier this week against the state and two hospital systems, alleging dangerous conditions that put health workers at risk and inflamed the country's largest coronavirus outbreak. It is among the first collective legal actions taken by health workers over the handling of the coronavirus outbreak by hospital administrators and state government. The union, which represents 42,000 nurses across New York, allege that the New York Department of Health failed to provide health workers with adequate protective equipment and directed health workers infected by Covid-19 to return to work sooner than advised by the state. The union also sued the Montefiore Medical Center system and the Westchester Medical Center, describing conditions in both hospital systems as "a war zone."
-Will Feuer | | | | New York state rolls out antibody testing | Gov. Andrew Cuomo said this week that an estimated 13.9% of the New Yorkers have likely had Covid-19, according to preliminary results of coronavirus antibody testing. The state randomly tested 3,000 people at grocery stores and shopping locations across 19 counties in 40 localities to see if they had the antibodies to fight the coronavirus, indicating they have had the virus and recovered from it, Cuomo said. With more than 19.4 million people residents, according to U.S. Census data, the preliminary results indicate that at least 2.7 million New Yorkers have been infected with Covid-19. The New York City area had the largest concentration of positive antibody test results at 21.2%. While Cuomo cautioned that the data was preliminary and only included people who travelled outside the home, he also said the 3,000 test sample was a "significant data set."
-Noah Higgins-Dunn | | | | WHO warns virus remains 'extremely dangerous' and 'will be with us for a long time' | The World Health Organization warned world leaders this week that they will need to manage around the coronavirus for the foreseeable future as cases level off or decline in some countries, while peaking in others and resurging in areas where the Covid-19 pandemic appeared to be under control. While social distancing measures were put in place in numerous countries to slow the spread of the coronavirus have been successful, the virus remains "extremely dangerous," WHO said. Current data shows "most of the world's population remains susceptible," the agency said, meaning outbreaks can easily "reignite."
-Berkeley Lovelace Jr. | | Healthy Returns Virtual Summit | May 12, 2020
The path forward for the health care industry at a time of unprecedented challenges
CNBC presents a virtual event featuring top health care CEOs, technologists and investors, exploring the ways the most innovative companies are addressing the coronavirus crisis, and the lasting effects the crisis will have on the industry.
From vaccines and treatments, to new tech and processes, to modeling the financial impacts and effects on legacy and upstart health care companies, Healthy Returns will feature some of the most influential voices in health care.
Led by CNBC's anchors and reporters, Healthy Returns will hone in on the groundbreaking ideas that will help mitigate the global pandemic, and will transform the health care industry for years to come. | |
Post a Comment